Gofen & Glossberg’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $96M | Sell |
543,403
-3,275
| -0.6% | -$565K | 2.47% | 6 |
|
|
2022
Q3 | $89.3M | Sell |
546,678
-1,953
| -0.4% | -$330K | 2.52% | 4 |
|
|
2022
Q2 | $97.4M | Sell |
548,631
-9,496
| -2% | -$1.69M | 2.59% | 5 |
|
|
2022
Q1 | $98.9M | Sell |
558,127
-2,794
| -0.5% | -$475K | 2.25% | 7 |
|
|
2021
Q4 | $96M | Sell |
560,921
-738
| -0.1% | -$121K | 2.07% | 8 |
|
|
2021
Q3 | $90.7M | Sell |
561,659
-344
| -0.1% | -$58.7K | 2.13% | 8 |
|
|
2021
Q2 | $92.6M | Buy |
562,003
+4,911
| +0.9% | +$813K | 2.2% | 6 |
|
|
2021
Q1 | $91.6M | Buy |
557,092
+7,368
| +1% | +$1.19M | 2.35% | 5 |
|
|
2020
Q4 | $86.5M | Sell |
549,724
-3,647
| -0.7% | -$538K | 2.37% | 6 |
|
|
2020
Q3 | $82.4M | Sell |
553,371
-1,380
| -0.2% | -$204K | 2.53% | 5 |
|
|
2020
Q2 | $78M | Sell |
554,751
-4,666
| -0.8% | -$680K | 2.62% | 5 |
|
|
2020
Q1 | $73.4M | Buy |
559,417
+4,800
| +0.9% | +$681K | 2.87% | 5 |
|
|
2019
Q4 | $80.9M | Sell |
554,617
-3,741
| -0.7% | -$507K | 2.57% | 6 |
|
|
2019
Q3 | $72.2M | Sell |
558,358
-2,468
| -0.4% | -$325K | 2.44% | 6 |
|
|
2019
Q2 | $78.1M | Sell |
560,826
-1,899
| -0.3% | -$263K | 2.68% | 5 |
|
|
2019
Q1 | $78.7M | Sell |
562,725
-1,861
| -0.3% | -$249K | 2.79% | 4 |
|
|
2018
Q4 | $72.9M | Buy |
564,586
+5,735
| +1% | +$800K | 2.88% | 3 |
|
|
2018
Q3 | $77.2M | Sell |
558,851
-674
| -0.1% | -$89.6K | 2.65% | 6 |
|
|
2018
Q2 | $67.9M | Buy |
559,525
+4,642
| +0.8% | +$579K | 2.52% | 5 |
|
|
2018
Q1 | $71.1M | Sell |
554,883
-3,255
| -0.6% | -$440K | 2.66% | 3 |
|
|
2017
Q4 | $78M | Buy |
558,138
+339
| +0.1% | +$47.2K | 2.79% | 3 |
|
|
2017
Q3 | $72.5M | Sell |
557,799
-6,491
| -1% | -$860K | 2.69% | 4 |
|
|
2017
Q2 | $74.7M | Sell |
564,290
-2,097
| -0.4% | -$268K | 2.84% | 2 |
|
|
2017
Q1 | $70.5M | Buy |
566,387
+740
| +0.1% | +$88.4K | 2.76% | 3 |
|
|
2016
Q4 | $65.2M | Sell |
565,647
-3,817
| -0.7% | -$441K | 2.66% | 3 |
|
|
2016
Q3 | $67.3M | Sell |
569,464
-3,494
| -0.6% | -$424K | 2.79% | 2 |
|
|
2016
Q2 | $69.5M | Buy |
572,958
+872
| +0.2% | +$99.1K | 2.91% | 2 |
|
|
2016
Q1 | $61.9M | Buy |
572,086
+10,831
| +2% | +$1.12M | 2.64% | 2 |
|
|
2015
Q4 | $57.7M | Sell |
561,255
-25,686
| -4% | -$2.58M | 2.5% | 3 |
|
|
2015
Q3 | $54.8M | Sell |
586,941
-2,558
| -0.4% | -$247K | 2.49% | 2 |
|
|
2015
Q2 | $57.5M | Buy |
589,499
+7,747
| +1% | +$776K | 2.43% | 3 |
|
|
2015
Q1 | $58.5M | Sell |
581,752
-1,119
| -0.2% | -$114K | 2.52% | 2 |
|
|
2014
Q4 | $61M | Sell |
582,871
-2,592
| -0.4% | -$273K | 2.62% | 2 |
|
|
2014
Q3 | $62.4M | Sell |
585,463
-6,055
| -1% | -$628K | 2.76% | 3 |
|
|
2014
Q2 | $61.9M | Buy |
591,518
+176
| +0% | +$17.8K | 2.73% | 4 |
|
|
2014
Q1 | $54.5M | Buy |
591,342
+2,226
| +0.4% | +$206K | 2.54% | 4 |
|
|
2013
Q4 | $54M | Sell |
589,116
-2,563
| -0.4% | -$236K | 2.53% | 4 |
|
|
2013
Q3 | $51.3M | Sell |
591,679
-2,899
| -0.5% | -$260K | 2.64% | 4 |
|
|
2013
Q2 | $51M | Buy |
+594,578
| New | +$50.5M | 2.77% | 4 |
|
Other funds holding JNJ
AWA
Gofen & Glossberg's JNJ Position: Q4 2022 in Review
Gofen & Glossberg reduced its Johnson & Johnson (JNJ) stake by 0.6% in Q4 2022, selling an estimated $565K and leaving 543,403 shares worth $96M. The position accounts for 2.47% of the portfolio, ranked #6.
Gofen & Glossberg first reported a position in JNJ in Q2 2013 and has held it in 39 quarters since. The position peaked at $98.9M in Q1 2022. 3,789 funds tracked by Wall St. Rank hold JNJ as of Q4 2022.
- Gofen & Glossberg held 543,403 shares of Johnson & Johnson worth $96M as of Q4 2022.
- Gofen & Glossberg sold 3,275 Johnson & Johnson shares in Q4 2022, an estimated $565K.
- Johnson & Johnson made up 2.47% of Gofen & Glossberg's portfolio in Q4 2022, its #6 holding.
- Gofen & Glossberg first reported a position in Johnson & Johnson in Q2 2013 and has held it in 39 quarters since.
- Gofen & Glossberg's Johnson & Johnson position peaked at $98.9M in Q1 2022.
- 3,789 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2022.
Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.